Targeting abdominal obesity in diabetes. (July 2015)

• Record Type: Journal Article
• Authors: Min, Thinzar; Stephens, Jeffrey Wayne
• Is Part Of: Diabetes management. Volume 5:Number 4(2015)
• Page Start: 301
• Page End: 309
• Publication Date: 2015-07
• Subjects: adipose tissue -- metabolic syndrome -- obesity -- Type 2 diabetes -- visceral fat; Diabetes -- Periodicals; 616.462005
• DOI: 10.2217/dmt.15.14
• Languages: English
• ISSNs: 1758-1915

Abstract

SUMMARY : Over recent years, there has been a better understanding of the role of that visceral adipose tissue plays in the pathogenesis of insulin resistance, Type 2 diabetes and the metabolic syndrome. Studies have consistently demonstrated that intra-abdominal fat accumulation, in other words, abdominal obesity is independently associated with Type 2 diabetes, hypertension, cardiovascular disease, nonalcoholic fatty liver disease and the metabolic syndrome. Furthermore, evidence supports the view that visceral adipose tissue is more closely associated with obesity related co-morbidities and mortality, compared with the total body adipose tissue (subcutaneous and visceral adipose tissue). The management of abdominal obesity involves a multidisciplinary team approach. Active healthy life style is a key in preventing obesity epidemic. Surgical intervention has become part of obesity treatment.